Search

everythinglearnresearchcommunity

for

Search:↓

Lower LDL-c levels predict higher COVID-19 mortality.

Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Passiflora incarnata may help with anxiety and sleep issues but has side effects; teleconsultation for heart failure can improve quality of life; increased screen time for children during the pandemic led to more clinical complaints; older and severely affected COVID-19 patients are more likely to have long-term symptoms.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Monocytes might be linked to hair loss after COVID-19.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.